| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Letters to the Editor |
Università di Reggio Calabria 88100 Catanzaro, Italy
G. Grasso and Osp. S. Pietro e Gravina
Caltagirone, Italy
S. Tumino and A. Belfiore
Universitá di Catania 95123 Catania, Italy
We would like to thank Drs. Baloch and Livolsi for their interest in our work (see preceding letter) and for the opportunity they give us to add some details about the hyperfunctioning insular thyroid carcinoma we described (1). The original slides have now been reviewed by two additional experienced pathologists, and both have confirmed the original diagnosis of insular carcinoma on the basis of the following characteristics. Both the primary tumor and the metastatic lymph node were almost entirely composed of nests of cells, surrounded by a rim of hyalinized collagen, and occasionally, by thick fibrous tissue and artificial clefts. The neoplastic cells were small, with scanty, pale, eosinophilic cytoplasm and with rather uniform morphology. The nuclei were regular and round, with chromatin arranged in small clumps. The nucleolus was generally inconspicuous and only rarely prominent, at variance with what we stated in our original report. Necrosis was absent. Although necrosis is a frequent feature in insular carcinoma, it is not an invariable finding, as it was absent in 21 out of 31 cases in the series reported by Papotti et al. (2). Mitoses were present but not frequent, on average 2 per 10 high power fields, a frequency well within the range reported in the literature (1:10 per 10 high power fields) (2, 3, 4). As mentioned in the original description, neither cytological (ground glass nuclei, pseudoinclusions, grooves) nor structural characteristics (papillae, psammoma bodies) suggesting a papillary carcinoma were present.
In summary, the review of the original slides indicated that the case described was indeed a typical insular carcinoma and provided no evidence for the diagnosis of a papillary carcinoma with a solid growth pattern, as hypothesized by Drs. Baloch and Livolsi. These aspects are better documented by the photomicrographs enclosed and are available upon request from the editorial office.
From the clinical point of view the aggressive behaviour of this tumor is documented by its clinical evolution. After total thyroidectomy the patient was treated with a cumulative dose of 650 mCi radioiodine in 4 yr for diffuse lung metastases and, although these metastases showed a good radioiodine uptake, to date they have not been cured.\.
|
|
1 Address correspondence to:
Antonino Belfiore, Istituto di Medicina Interna e di Malattie Endocrine
del Metabolismo, Università di Catania, Catania, Italy
95123. ![]()
Received August 8, 1997.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |